Azathioprine plus ribavirin treatment and pancytopenia

Alimentary Pharmacology and Therapeutics

Volumn 30, Issue 9, 2009, Pages 962-963

  Chaparro, M ^a   Trapero Marugan M ^a   Moreno Otero, R ^a   Gisbert, J P ^a  

^a Centro de Investigación Biomédica en Red de Cáncer CIBERONC University of Barcelona   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; PEGINTERFERON ALPHA2B; RIBAVIRIN;

ADULT; ANEMIA; CASE REPORT; CROHN DISEASE; DRUG EFFECT; DRUG METABOLISM; DRUG WITHDRAWAL; HEPATITIS C; HUMAN; LETTER; MALE; NEUTROPHIL COUNT; PANCYTOPENIA; PRIORITY JOURNAL; RETREATMENT; SIDE EFFECT;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIVIRAL AGENTS; AZATHIOPRINE; CROHN DISEASE; DRUG INTERACTIONS; HEPATITIS C, CHRONIC; HUMANS; MALE; PANCYTOPENIA; RIBAVIRIN;

EID: 70349659926     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2009.04109.x     Document Type: Letter

References (6)

1. Peyrin-Biroulet L, Cadranel JF, Nousbaum JB, et al. Interaction of ribavirin with azathioprine metabolism potentially induces myelosuppression. Aliment Pharmacol Ther 2008 28 : 984 993.
2. Loras C, Saro C, Gonzalez-Huix F, et al. Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain: a nationwide, multicenter study. Am J Gastroenterol 2009 104 : 57 63.
3. Bargiggia S, Thorburn D, Anderloni A, et al. Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case-control study Aliment Pharmacol Ther 2005 22 : 209 215.
4. Salcedo-Mora X, Mate J, Medina J, Nam Cha SJ, Gisbert JP, Moreno-Otero R. Chronic hepatitis C and Crohn's disease: nosocomial infection treatment with PEG-interferon plus ribavirin. Digestion 2006 73 : 210 214.
5. Hindorf U, Lindqvist M, Peterson C, et al. Pharmacogenetics during standardised initiation of thiopurine treatment in inflammatory bowel disease. Gut 2006 55 : 1423 1431. (Pubitemid 44476786)
6. Gilissen LP, Derijks LJ, Verhoeven HM, et al. Pancytopenia due to high 6-methylmercaptopurine levels in a 6-mercaptopurine treated patient with Crohn's disease. Dig Liver Dis 2007 39 : 182 186.